BRIDGEWATER, N.J. The United States subsidiary of Sanofi-Aventis announced Monday that starting Jan. 1, it will increase access to its Patient Assistance Programs to include uninsured patients with incomes up to 250 percent of the federal poverty level.
Sanofi said the PAPs, which will not include cancer drugs, assist low-income patients in gaining access to the company’s prescription medications by focusing on individual patients and acting as a resource for them and their advocates.
“Sanofi-Aventis U.S. remains committed to making our prescription medicines available to uninsured and low-income patients through our PAPs,” Sanofi-Aventis president and chief executive officer Greg Irace said in a statement. “We have taken several steps to help patients with the greatest financial need access these medications.”
The PAPs include medicines for diabetes, rheumatoid arthritis, blood-clotting problems, allergies, skin disorders and urological disorders.